Oct4 and Oct5 are two mouse maternally expressed proteins binding to the octamer motif. Both 
Introduction
The molecular mechanisms that regulate mammalian embryogenesis are poorly understood. It is assumed that a network of regulatory genes controls the transformation of genetic information into embryonic structure. During recent years a number of mouse homeobox and paired-box containing genes were identified on the basis of sequence similarity to Drosophila genes (for review see Dressler and Gruss, 1988) . While the expression patterns (for refs see Holland and Hogan, 1988) and mutational transgene studies concerning Pax and Hox genes (Balling et al., 1988 indicate a role in pattern formation, developmental activation of these genes is restricted to post-implantation stages of mouse development. Moreover, the exact function and target sites remain unknown (Dressler and Gruss, 1988) .
Octl and Oct2 are mammalian homeo-domain containing proteins whose target sequence is known, and are regarded to be ubiquitous and cell-specific transcription factors respectively. Expression of the Oct2 cDNA is sufficient for strong transcriptional activation of B-cell promoters (Muller et al., 1988) . A family of octamer binding proteins has been described in the accompanying report (Scholer et al., 1989) . Two of these proteins, namely Oct4 and Oct5, are found in mouse oocytes. Therefore, these maternally expressed proteins are prime candidates for regulatory factors active in pre-implantation stages of mouse development.
In the present study, the transcriptional activity of the octamer-motif is investigated in cells containing Oct4 and Oct5. Oct4 is found in cells representing the germ line, such as primary germ cells (PGC) and unfertilized oocytes, and also in pluripotent embryonic stem cells (see Scholer et al., 1989) . However, Oct4 is not found in sperm and any other tissues of the mouse. Similarly, Oct5 is detectable in extracts of unfertilized oocytes and also in embryonic stem (ES) cells. Oligomers of the octamer motif activate transcription in B-cells, where Oct2 is present (Gerster et al., 1987 and refs therein) . Here it is demonstrated that the octamer motif can also strongly activate transcription in F9 and D3 stem cells which do not contain detectable levels of Oct2 but consider- (Banerji et al., 1983 ) is schematically shown with the binding sites found by genomic sequencing Ephrussi et al., 1985 (Scholer et al., 1989 (Scholer et al., 1989 Oligomerization of transcriptional motifs can create powerful enhancer elements with distinct tissue-specificities (Ondeck et al., 1987; Schirm et al., 1987 ; for a review see Scholer et al., 1988) . In particular, oligomers of an IgH enhancer fragment containing the octamer motif (1W in Figure 1 ) are strong B-cell specific enhancers where Oct2 is present, but are inactive where only Octl is present (Gerster et al., 1987) . We were interested to test if this synthetic enhancer is also active in the F9 cell line which contains the newly identified proteins Oct4 and OctS.
An hexamer of 1W (named 6W) was cloned in front of a minimal thymidine kinase (TK) promoter whose intrinsic octamer motif had been removed (p6WTKCAT) and transfected into F9 stem cells. As positive controls plasmids containing the RSV and the SV40 enhancer/promoter regions were used (pRSVCAT and pSV2CAT). The results in Table I show that the 6W enhancer stimulates transcription at least 1100-fold as compared to the enhancer-less plasmid, although an exact determination is difficult due to the low basal activity of the TK promoter in these cells. Nevertheless, the levels of CAT activity obtained with p6WTKCAT in F9 UD cells are -8-and -20-fold higher than those obtained in pRSVCAT and pSV2CAT respectively. When F9 cells are induced to differentiate, the activity mediated by 6W drops 20-fold to levels below that of pRSVCAT and pSV2CAT. This reduction correlates with the decrease in binding of the octamer proteins observed in vitro.
The 6W enhancer activates different promoters The 6W enhancer was cloned in front of the SV40 early promoter to test if the stimulation mediated by the octamer motif is conferred to different promoters. Again, transcription is stimulated by the 6W enhancer in F9 stem cells and this stimulation drops after their differentiation (Table I) .
Therefore the effect of the 6W enhancer is not restricted to the TK promoter. However, the 6W enhancer stimulates the (LeBowitz et al., 1988) . Most importantly, these experiments make it unlikely that the activity of the 6W enhancer in F9 cells is due to Octl.
The activity of the 6W enhancer is dependent on the octamer motif To investigate if the stimulation in F9 cells is mediated by the octamer motif, mutations were introduced in the octamer motif and in the jtE4 binding sites (Figure 1 ). Similar mutations have also been used to study the B-cell activity of this enhancer (Gerster et al., 1987) . The mutations were Hexamers of IW(e-) and lW(o-) were cloned in front of the TK promoter and their activity in F9 stem cells was compared to p6WTKCAT. The octamer mutation completely abolished enhancement of the TK promoter, while altering the AE4 motif only had a minor effect (Table I (Evans and Kaufman, 1981; Martin, 1981) which colonize the germ line regularly and contribute to all somatic cell lineages (Bradley et al., 1984) .
For this purpose the embryo-derived stem (ES) cell line Fig. 5 . Expression patterns of p6WTKLacZ in four independent 3.5 day blastocysts. D3 was used (Doetschman et al., 1985) which contains Oct4 and Oct5 (Scholer et al., 1989) . For the functional analysis of the octamer motif, p6WTKCAT was transfected into D3 stem cells in parallel with pRSVCAT and pTKCAT as positive and negative controls. As in F9 cells, the 6W enhancer was very active in D3 stem cells and, as expected from the in vitro results, stimulation decreases significantly after differentiation (Figure 4 and Table III, see also Scholer et al., 1989) . Therefore the activity of the octamer motif and the presence of the Oct factors correlate in both the ES cell line D3 and the EC cell line F9. 6WTKLacZ shows expression in the inner cell mass of blastocysts Most experiments investigating the activity of the 6W enhancer in ES cells were performed using CAT as a reporter gene. In parallel these results were supplemented by experiments with two plasmids in which the CAT gene was replaced by lacZ. These plasmids -pTKLacZ and p6WTKLacZ -were transfected into F9 and D3 stem cells. As expected, the TK promoter alone gave only a small number of blue cells in both cell lines and addition of the 6W enhancer increased this number significantly (not shown). In this case the increase was -5000-fold and therefore even higher as determined with the CAT assay.
As the ES cell line D3 had been isolated directly from 3 day blastocysts, we were interested in extending these results to the pre-implantation embryo. 6WTKLacZ and 6WTKLacZ(o-) which carries a mutation in the octamer motif as described above were microinjected into fertilized oocytes. The injected oocytes were cultured in vitro to the blastocyst stage or transferred to a foster mouse. After 3 days the uteri of these mice were isolated and the blastocysts recovered.
Ninety-four oocytes were injected with 6WTKLacZ and 40 with 6WTKLacZ(o-). From these, 28 and 14 blastocysts were obtained respectively. None of the oocytes injected with 6WTKLacZ(o-) gave rise to blastocysts with detectable LacZ expression. In contrast, the transgene was active in six independent blastocysts injected with 6WTKLacZ. In five of them, activity was clearly detected in the ICM region while in one case expression was found in a few cells of the polar trophectoderm (not shown). The pattern of activity, for four blastocysts, clearly shows blue cells in the ICM ( Figure 5 ). Interestingly, the activity seems to be restricted to only a few cells of the ICM. To visualize better this restriction, top and side views of one blastocyst are shown in Figure 6 .
Discussion
Oct4 and OctS are maternally expressed octamer binding proteins found in the pre-implantation stages of mouse development (Scholer et al., 1989) . Embryonic stem cells, which contain Oct4 and OctS, were used as a model to study the activity of the octamer in the pre-implantation embryo. So far it was assumed that oligomerization of the IgH octamer motif acts only as a strong enhancer in cells containing Oct2 (Gerster et al., 1987) . We demonstrate that the same enhancer, named 6W, strongly stimulates different promoters in ES cells. Therefore such an enhancer is also active in the abence of Oct2 when Oct4 and OctS are present. After differentiation of the stem cells, both enhancer activity and the amount of the octamer binding proteins decrease. (Scholer et al., 1989) . Although much less abundant, a stimulation of the enhancer activity could also be due to Oct5 or Oct6 since high amounts of complexes do not necessarily correlate with stimulation.
The high activity of the 6W enhancer in these cells is presumably not due to Oct . The amount of Oct 1 decreases only slightly after differentiation and cannot explain the dramatic decrease of transcriptional activity observed in vivo. Moreover, transfection experiments in cell lines where only OctI is detectable show that the 6W enhancer is at least two orders of magnitude less active than in cells containing other octamer binding proteins. In this respect, ES cells are similar to B-cells in which the same enhancer strongly stimulates transcription due to Oct2 (Gerster et al., 1987) . It is possible though that Octl acts synergistically with either Oct4 and/or Oct5 to stimulate transcription.
The results presented here are in apparent contradiction with previously published data. Fromental et al. (1988) could not demonstrate any activity of the SV40 octamer in F9 cells although the same constructs are active in B-cells. This particular arrangement of the SV40 octamer sequence motifs in different enhancers might be unfavourable for binding of the factors found in F9 cells. As shown in the accompanying paper (Scholer et al., 1989) , binding of the factors is strongly affected when the surrounding sequences of the IgH octamer are altered.
In a recent publication, the octamer motif of the IgH enhancer repressed transcription in F9 stem cells. In this study, an IgH fragment harbouring the jtE3 site in addition to the 14E4 and octamer sites was placed in front of a truncated promoter of the fos gene (Lenardo et al., 1989) . The activity of this fragment was compared with that of mutations in the different motifs. Whenever an intact octamer motif was present, AE3 could not stimulate the fos promoter.
Only when the octamer motif was mutated could a weak activity be demonstrated for the 1E3 motif. Thus it appears that thefos promoter is not directly influenced by the octamer sequences but that the effect of the 14E3 motif is blocked by the binding of proteins to the octamer motif.
These apparently contradictory results could be explained as follows. In the case of the 6W enhancer the arrangement of the various motifs might allow protein binding without steric hindrance, thereby enabling the octamer protein(s) to participate actively in a transcriptional complex. In the case of the fos promoter/IgH enhancer constructs, the motifs might be placed in such a way that binding of the octamer protein(s) would hinder formation of a transcriptional complex. This explanation is not unlikely since a similar effect of the octamer motif has been previously demonstrated (Parslow et al., 1987) . In this study the TK promoter containing the octamer motif was placed under the influence of the Igx light chain and the MSV enhancer. When the Igx enhancer was used in B-cells, mutations in the octamer reduced activity. If the MSV enhancer was used, then mutations in the octamer motif increased transcriptional enhancement. These findings strengthen the presumption that the particular context in which a transcription motif is found can influence its properties.
Another explanation for the contradictory results is that the inhibitory effect described by Lenardo et al. (1989) (Scholer et al., 1989 
Materials and methods
Cell lines and transfection F9, 3T3, Hep3 (human hepatoma), BJA-B and HeLa cells were grown as described previously Gruss, 1984, 1985) . D3 cells were cultured as described by propagating them in highly purified, recombinant LIF to maintain the undifferentiated phenotype (Williams et al., 1988b) . The F9 (UD) cells were differentiated to F9 (D) by treating them 48 h before harvest with 5 x 10-7 M retinoic acid and 10-3 M cAMP. To differentiate D3 cells, LIF was omitted and both retinoic acid and dibutyryl cAMP were added to final concentrations of l0-7 and 10-3 M respectively (Doetschman et al., 1985; Williams et al., 1988a) .
The F9 cells were transfected as described elsewhere (Scholer and (Strickland et al., 1980) . The cells were harvested 48 h after changing the medium.
The undifferentiated D3 cells were transfected as described elsewhere (Scholer and Gruss, 1984) , with the exception that 5 cm dishes were used and the DNA -calcium phosphate precipitate was left on the cells for 20 h. The cells were subsequently trypsinized and plated on two 10 cm tissue culture dishes and maintained for 48 h in medium with or without LIF (see above).
CAT assays were performed as described elsewhere (Scholer and Gruss, 1984) with one modification: after sonication the complete extract was incubated for 10 min at 60°C to denature proteases and afterwards cooled on ice.
LacZ detection in blastocysts and in cultured cells Fertilized oocytes were obtained from outbred NMRI mice. All procedures to obtain the microinjected blastocysts are essentially as described by Hogan et al. (1986) . The blastocysts were first washed twice in PBS and fixed in 0.25 % glutaraldehyde at 4°C for staining. After 10 min they were washed four times in PBS and stained in a solution of 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-13-D-galactopyranoside), 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 and 2 mM MgCI2 in PBS.
The procedure for LacZ detection in cultured cells is as described for blastocysts, except that cells were fixed in methanol.
Preparation of nuclear extracts Nuclear extracts of the cell lines were prepared according to the protocol of Dignam et al. (1983) . Nuclear extracts from mouse tissues and embryos were prepared according to the method of Gorski et al. (1986) including a mixture of protease inhibitors: PMSF (0.5 mM), leupeptin (0.5 jig/ml), pepstatin (0.7 Ag/ml), aprotinin (1 /Ag/ml) and bestatin (40 jg/ml) in the homogenization buffer.
Electrophoretic mobility shift assay (EMSA) Binding conditions for the EMSA were 10 mM Hepes, pH 7.8 (4°C), 1 mM spermidine, 5 mM MgCI2, 50 mM KCI, 0.5 mM DTT, 9% glycerol, 1 jg polyd(I C), 10 000 c.p.m. of the labelled oligonucleotide. The final reaction volume was 15 ,u. After an incubation for 15 min at 25°C the binding reaction was applied to gel electrophoresis as described by Singh et al. (1986) .
Oligonucleotides
The numbering of all oligonucleotides is according to Ephrussi et al.(1985) .
1W is identical to region 518-564 except for position 562 (Gerster et al., 1987) . In lW(e-) the 1W oligonucleotide is changed at positions 531, 532
and 535 to A, C and G respectively. In lW(o-) the 1W oligonucleotide is changed at the positions 543 and 545 to G and T. The octamer motif (541-548) is underlined. el-wt (334-380), e2-wt (385-417) and e4-wt (527-541) are identical to the regions containing binding sites found by genomic footprinting of B-cells Ephrussi et al., 1985) .
The sequences of the coding strands of 1W and e4-wt are shown.
Recombinant plasmids
Construction of p6WSTKCAT, p6W,SVICAT and p6WaSVICAT: the EcoRI-EcoRlfragment of the FD hexamer (Gerster et al., 1987) , referred to here as 6W, was first cloned into the EcoRI site of the Bluescript polylinker. Using the XbaI and the HindIII sites of the vector polylinker the 6W fragment was cloned in the same sites of pTKCAT. Fragments carrying mutated motifs were similarly cloned. pTKCAT is derived from pBLCAT2 (Luckow and Schutz, 1987) by inserting two SV40 termination signals in front of the pBLCAT2 polylinker to decrease unspecific transcription (M.Koenen, personal communication). The position of the termination signal in the SV40 genome is 2533 (BamHI) to 2770 (Sau3A) according to Tooze (1981) . The octamer motif, which is an intrinsic part of the TK promoter, is not present in pTKCAT (Luckow and Schuitz, 1987; Parslow et al., 1987) . For p6W,SVICAT and p6WaSVICAT, the 6W fragment was isolated from the Bluescript construct by cutting the polylinker with BamHI and BglII and recloning the fragment in both orientations 5' of the SV40 promoter in pSV 1CAT. pSVlCAT, pSV2CAT and pRSVCAT are described by Gorman et al. (1985) . p6WTKLacZ, pTKLacZ and p6WTKLacZ(o-) were constructed by replacing the CAT gene of the respective CAT plasmids by a HindIII-BamHI fragment containing the lacZ gene. The LacZ fragment was derived from pCHl 10 (Pharmacia). The 4 kb fragment used for microinjection was isolated after restricting the 7 kb plasmid with SphI and SacII.
